Financials The Cannabist Company Holdings Inc. NEO Exchange
Equities
CBST
CA13765Y1034
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 CAD | +18.00% |
|
+13.46% | -50.00% |
06-26 | Transcript : The Cannabist Company Holdings Inc. - Shareholder/Analyst Call | |
06-26 | The Cannabist Company and Bloom Introduce Vape Brand to New East Coast Markets | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 538.3 | 1,756 | 1,076 | 309.3 | 193.5 | 103.2 | - | - |
Enterprise Value (EV) 1 | 497.1 | 1,991 | 1,415 | 828.4 | 704.1 | 592.7 | 549.5 | 103.2 |
P/E ratio | -5.08 x | -12.6 x | -6.81 x | -0.71 x | -1.05 x | -1.15 x | -2.93 x | 3.66 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 6.95 x | 9.78 x | 2.27 x | 0.6 x | 0.38 x | 0.2 x | 0.18 x | 0.15 x |
EV / Revenue | 6.42 x | 11.1 x | 2.99 x | 1.62 x | 1.38 x | 1.17 x | 0.97 x | 0.15 x |
EV / EBITDA | -10.6 x | -481 x | 16.6 x | 12.3 x | 10.1 x | 8.15 x | 5.34 x | 0.88 x |
EV / FCF | -3.62 x | -23.3 x | -12 x | -4.5 x | -282 x | 6.89 x | - | - |
FCF Yield | -27.6% | -4.29% | -8.34% | -22.2% | -0.35% | 14.5% | - | - |
Price to Book | - | 4.9 x | 1.76 x | - | 2.81 x | - | - | - |
Nbr of stocks (in thousands) | 216,199 | 290,319 | 376,209 | 412,452 | 430,221 | 469,645 | - | - |
Reference price 2 | 2.490 | 6.050 | 2.860 | 0.7500 | 0.4498 | 0.2198 | 0.2198 | 0.2198 |
Announcement Date | 10/03/20 | 03/03/21 | 14/03/22 | 29/03/23 | 13/03/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 77.46 | 179.5 | 473.8 | 511.6 | 511.3 | 507.1 | 568.6 | 689.7 |
EBITDA 1 | -46.94 | -4.138 | 85.07 | 67.38 | 69.64 | 72.77 | 102.9 | 116.7 |
EBIT 1 | -92.89 | -74.1 | -110.4 | -113.5 | -105.2 | 2.191 | 40.8 | 70.6 |
Operating Margin | -119.92% | -41.28% | -23.29% | -22.18% | -20.58% | 0.43% | 7.18% | 10.24% |
Earnings before Tax (EBT) 1 | - | -136.9 | -146.7 | -432.7 | -168.9 | -46.9 | -13 | 38.3 |
Net income 1 | -102.6 | -110.8 | -143.1 | -416 | -175.7 | -88.36 | -45 | 28.2 |
Net margin | -132.44% | -61.71% | -30.2% | -81.32% | -34.36% | -17.42% | -7.92% | 4.09% |
EPS 2 | -0.4900 | -0.4800 | -0.4200 | -1.060 | -0.4300 | -0.1912 | -0.0750 | 0.0600 |
Free Cash Flow 1 | -137.2 | -85.49 | -118 | -184.1 | -2.495 | 86.04 | - | - |
FCF margin | -177.11% | -47.63% | -24.91% | -35.99% | -0.49% | 16.97% | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | 118.23% | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 10/03/20 | 03/03/21 | 14/03/22 | 29/03/23 | 13/03/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 139.3 | 123.1 | 129.6 | 132.7 | 126.2 | 124.5 | 129.2 | 129.2 | 128.4 | 122.6 | 124.4 | 126.7 | 131.5 | 131.6 | 138 |
EBITDA 1 | 27.21 | 16.83 | 12.03 | 20.99 | 17.4 | 16.36 | 20.32 | 20.49 | 12.47 | 15.3 | 16.74 | 18.6 | 20.47 | 25.9 | 27.6 |
EBIT 1 | -84.84 | -14.66 | -22.11 | -18.71 | -58 | -8.269 | 0.049 | -19.33 | -77.69 | -10.74 | -1.549 | 0.6475 | 3.773 | 0.9 | 5.3 |
Operating Margin | -60.92% | -11.91% | -17.06% | -14.1% | -45.96% | -6.64% | 0.04% | -14.96% | -60.52% | -8.76% | -1.24% | 0.51% | 2.87% | 0.68% | 3.84% |
Earnings before Tax (EBT) 1 | -53.89 | -27.27 | -35.55 | -31.73 | -338.1 | -25.88 | -22.73 | -33.88 | -86.4 | -25.7 | -15.69 | -13.44 | -10.31 | -14 | -9.7 |
Net income 1 | -53.28 | -26.64 | -53.83 | -35.43 | -300.1 | -37.34 | -28.86 | -36.72 | -72.78 | -35.07 | -25.19 | -23.61 | -21.38 | -25.1 | -21.8 |
Net margin | -38.25% | -21.64% | -41.54% | -26.69% | -237.83% | -29.98% | -22.33% | -28.43% | -56.7% | -28.61% | -20.25% | -18.63% | -16.26% | -19.07% | -15.8% |
EPS 2 | -0.1400 | -0.0700 | -0.1400 | -0.0900 | -0.7500 | -0.0900 | -0.0700 | -0.0900 | -0.1800 | -0.0800 | -0.0457 | -0.0430 | -0.0363 | -0.0600 | -0.0500 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 14/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 29/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 13/03/24 | 09/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | 234 | 339 | 519 | 511 | 490 | 446 | - |
Net Cash position 1 | 41.3 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | -56.57 x | 3.987 x | 7.704 x | 7.331 x | 6.727 x | 4.338 x | - |
Free Cash Flow 1 | -137 | -85.5 | -118 | -184 | -2.5 | 86 | - | - |
ROE (net income / shareholders' equity) | -43.6% | -25.3% | -32.6% | -30.9% | - | -17.5% | 128% | - |
ROA (Net income/ Total Assets) | -32.3% | -12.7% | -13.6% | - | - | - | - | - |
Assets 1 | 318.1 | 873.3 | 1,052 | - | - | - | - | - |
Book Value Per Share | - | 1.240 | 1.630 | - | 0.1600 | - | - | - |
Cash Flow per Share 2 | -0.2800 | -0.1800 | - | - | - | 0.0600 | 0.1800 | - |
Capex 1 | 77.4 | 42.9 | 118 | 72.7 | 9.97 | 13.1 | 11.4 | - |
Capex / Sales | 99.98% | 23.89% | 24.8% | 14.22% | 1.95% | 2.59% | 2% | - |
Announcement Date | 10/03/20 | 03/03/21 | 14/03/22 | 29/03/23 | 13/03/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.04% | 261M | |
+2.06% | 211M | |
+27.91% | 167M | |
+43.67% | 130M | |
-42.86% | 96.6M | |
+300.00% | 121M | |
+71.19% | 96.17M | |
-23.08% | 66.82M |
- Stock Market
- Equities
- CBSTF Stock
- CBST Stock
- Financials The Cannabist Company Holdings Inc.